Bill Text

Bill Information


PDF |Add To My Favorites | print page

SJR-9 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.(2015-2016)

SHARE THIS:share this bill in Facebookshare this bill in Twitter
SJR9:v95#DOCUMENT

Senate Joint Resolution No. 9
CHAPTER 181

Relative to the Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.

[ Filed with Secretary of State  September 18, 2015. ]

LEGISLATIVE COUNSEL'S DIGEST


SJR 9, Stone. The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
This measure would urge the President and the Congress of the United States to enact the Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Fiscal Committee: NO  

WHEREAS, Approximately 50 years ago, kidney failure was a death sentence; and
WHEREAS, In 1972, Congress developed the Medicare End-Stage Renal Disease benefit. In doing so, Congress ensured that regardless of age or income, any American would have access to lifesaving dialysis care. That was the turning point in kidney care; and
WHEREAS, The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (HR 1130) was introduced in the House of Representatives by Representative Tom Marino to address kidney disease care; and
WHEREAS, House Resolution 1130 is built on three primary tenets. First, for individuals living with chronic diseases, especially when those diseases are complicated by multiple comorbid conditions, coordinated care is key to improving outcomes and lowering health care costs. Second, increased research can lead to a deeper understanding of kidney disease prevention and ultimately to significant innovations in treatment. Lastly, stability in the Medicare Program is central to an end-stage renal disease program that ensures quality and produces optimal results; and
WHEREAS, If left untreated, chronic kidney disease can progress to kidney failure, also known as end-stage renal disease, and early cardiovascular death; and
WHEREAS, More than 20 million adults in the United States, or more than 10 percent of the adult population, are estimated to have chronic kidney disease and most are undiagnosed; and
WHEREAS, Kidney disease is the ninth leading cause of death in the United States; and
WHEREAS, In the United States, diabetes and high blood pressure are the leading causes of kidney failure, accounting for 72 percent or about three out of four new cases of kidney failure; and
WHEREAS, The number of kidney failure cases in the United States population has more than tripled since 1990 and is expected to grow because of an aging population and the increasing number of people with conditions, such as diabetes and high blood pressure, that place them at the risk of developing chronic kidney disease; now, therefore, be it
Resolved by the Senate and the Assembly of the State of California, jointly, That the Legislature urges the President and the Congress of the United States to enact the Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (HR 1130); and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the President of the United States, to each Senator and Representative from California in the Congress of the United States, and to the author for appropriate distribution.